Dr. Birge received a B.S from the University of Connecticut (1984), and a PhD in Biochemical Toxicology (1989), also from the University of Connecticut. He completed postdoctoral training at The Rockefeller University in New York with Professor Hidesaburo Hanafusa from 1989 to1994 and was Assistant Professor in the Laboratory of Molecular Oncology at Rockefeller University from 1994 to 1998, and acting head of that same laboratory from 1998-2000. Dr. Birge joined UMDNJ-New Jersey Medical in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at The New Jersey Medical School Cancer Center (Newark) and The Cancer Institute of New Jersey (New Brunswick)
Dr. Birge's research focuses on apoptosis and cancer biology, emphasizing genes and signaling pathways that promote tumor progression, metastasis, and immune escape. He was the founding member (with Richard Lockshin and Zahra Zakeri) of the Cell Death Society and presently serves on the Board of Directors of the International Cell Death Society.
Dr. Birge serves as a scientific consultant on numerous federal and private grant study sections that includes the National Institutes of Health, National Science Foundation, and the Department of Defense Congressionally directed Breast and Prostate Cancer funding programs. He is currently on the editorial board of The Journal of Biological Chemistry, Frontiers in Immunology, and Editor-in-Chief for Cell Communication and Signaling. Dr. Birge has authored over 80 scientific publications and chapters in molecular biology, immunology, and cancer biology.